Chronic Lymphocytic Leukemia
Conditions
Keywords
Chronic Lymphocytic Leukemia, CLL, Dermal Chelation, Nutritional Therapy
Brief summary
The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy
Detailed description
The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.
Interventions
Dermal chelation with Aqua DetoxTM system for one or more hours one or more times each week.
Vitamins and minerals that will be taken one or more times a day.
Sponsors
Study design
Intervention model description
Clinical trials with a single arm
Eligibility
Inclusion criteria
* Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load * Toxic heavy metal load
Exclusion criteria
* Pregnant * Pacemaker implants * Organ transplant recipients * Psychotic episodes or epileptic seizures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serial Total White Blood Cell Count | up to 12 months | Total WBC counts taken on a regular interval. |